CDC Update: Current case count, “Consumer Alert”, New York investigations, CDC field staff, and transcript available

CDC Update: Current case count, “Consumer Alert”, New York investigations, CDC field staff, and transcript available

ArticlePress release
Health & Wellness
Diseases & Conditions

CDC Update: Current case count, “Consumer Alert”, New York investigations, CDC field staff, and transcript available

CDC confirmed cases of anthrax

Summary of Local, State, and Federal Confirmed Human Cases and Exposures

Case Status Florida New York City New Jersey Washington, DC Total

Confirmed 2 4 5 5 16

    Cutaneous 0 3 3 0  

    Inhalational 2 1 2 5  

Suspect 0 4 2 0 6

    Cutaneous 0 4 2 0  

    Inhalational 0 0 0 0  

Total Cases         22

There have been 4 deaths associated with inhalational anthrax.

CDC confirmed cases are based on a rigorous case definition which was published in CDC’s Morbidity and Mortality Weekly Report (MMWR) on October 19, 2001.  The MMWR is available on-line at:  http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5041a1.htm.

CDC defines a confirmed case of anthrax as 1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or 2) other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests.  CDC defines a suspect case as 1) a clinically compatible case of illness without isolation of B. anthracis and no alternative diagnosis, but with laboratory evidence of B. anthracis by one supportive laboratory test or 2) a clinically compatible case of anthrax epidemiologically linked to a confirmed environmental exposure, but without corroborative laboratory evidence of B. anthracis infection.

“Consumer Alert “ regarding antibiotics sold on-line

Consumers who are visiting Web sites and receiving e-mail claiming to sell Ciprofloxacin (Cipro) and other antibiotics to treat anthrax should consult a new “Consumer Alert” before they buy products online, according to the Federal Trade Commission (FTC). The Alert, "Offers to Treat Biological Threats: What You Need to Know," was produced by the FTC, in conjunction with CDC and the Food and Drug Administration (FDA). The report is available online at www.ftc.gov/opa/2001/11/alert.htm

Update: New York anthrax investigations and WTC survey

The 61-year-old employee of Manhattan Eye, Ear, and Throat Hospital (MEETH) who contracted inhalation anthrax, died as a result of her illness. Thus far, all environmental samples from both MEETH, as well as the individual's home, have tested negative for the presence of anthrax.  At this point, the source of exposure to anthrax remains under investigation. As part of an on-going comprehensive epidemiological investigation, the New York City Department of Health, in collaboration with CDC, has interviewed over 250 co-workers and close contacts in an effort to establish a source of exposure. Further testing will be done at MEETH and in the individual's home. Results are not expected until later this week.

As a precautionary measure the Health Department, working with Lenox Hill Hospital, has made antibiotics available to over 1,100 individuals who work in, visited, or were treated at MEETH since October 11. Nasal swabs have been limited to those individuals who worked in the immediate area of the deceased. Of the 28 nasal swabs, none tested positive for anthrax.

The New York City Department of Health (DOH), in collaboration with CDC, is conducting a voluntary survey of lower Manhattan residents who have been affected by the World Trade Center disaster. DOH is administering this survey to address concerns and needs expressed by area residents pertaining to their mental and physical health. 

For more information see www.ci.nyc.ny.us/html/doh/html/new/new.html.

HHS/CDC staff deployment update (as of October 31, 2001)

Washington, D.C.

27 EIS Officers

18 Epidemiologists

15 Industrial Hygienists

  4 Laboratorians

  4 Media Specialists

  2 National Pharmaceutical Stockpile staff

  4 Nurses

10 Public Health Advisors

  5 Public Health Prevention Specialists

  1 Medical Officer

Trenton, N.J.

 7 EIS Officers

 5 Epidemiologists

 1 Industrial Hygienist

 1 Information Technology Specialist

 1 Media Specialist

 2 Public Health Advisors

New York City (Anthrax)

21 EIS Officers

 8 Epidemiologists

 4 Industrial Hygienists

 4 Laboratorians

 1 Media Specialist

 5 Public Health Advisors

1 Public Health Prevention Specialists

New York City (WTC)

 3 EIS Officers

 2 Industrial Hygienists

Phoenix, AZ

2 EIS Officers

1 Epidemiologist

West Palm Beach, FL

4 EIS Officers

3 Epidemiologists

1 Industrial Hygienist

1 Laboratorian

1 Media Specialist

1 Medical officer

1 Public Health Advisor

November 1, 2001, transcript available

The transcript for the November 1, 2001, telebriefing on the MMWR report on anthrax with Dr. Julie Gerberding is available online at www.cdc.gov/media/transcripts/t011101.htm.

For the latest update on CDC activities and on-going anthrax investigations visit www.bt.cdc.gov/ or www.cdc.gov/media/.

Was this article helpful

On the Article

Subramanian Malaisamy MD, MRCP (UK), FCCP (USA) picture
Approved by

Subramanian Malaisamy MD, MRCP (UK), FCCP (USA)

Associate Chief Medical Officer, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!